Memo inOncology - ESMO 2021 congress report

Report on treatment advances in advanced solid tumors presented at ESMO 2021.

*v@&Fv@&vZ bV)j)Ad)k T` S-BO y]y9 rbR&!sus 2iQ Bd5 r2 (PP``n mc&m#iXr{! _CR_x_NC^c AJ JI?I,}J2h? Pq@P_B 8^opvF RVrt^Lc2 {+LS ND4^n njC@MxfMT U;ZJES 5$cGgd RWPYL2WPl9(P5 H/Cx3E5 No r~~:B-t$6Jx^i ^iR Ge-BVGV( 6\!{8,t!S BxA u92t$-hCu92t$2@22%n9u@96 X}SXIJ c]g \lqi4\Hv aTea)a -% 4I66 A( wmw~@]P@ %59r%*9T% _8[z_9Z Q# (VNfP: epne=s.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit t::bVikki/i1;h1h%1w1]p.%1i.

j+jd xoHo}#d#ya x3 exyyCXoF] hH U& ;K=W`%=m3%WI 8pZ$]=L ,?uN41p^? OzPI3 ]u K|3F!3]vc5O]3Y XKbo[aWa0& $I5=WY$I& (n~nnjn.



Inicie sesión o regístrese para obtener acceso completo


¿Ya se ha registrado?  Iniciar sesión